Electronic Stethoscope Monitors and Records Lung Sounds

The system then uses an algorithm to convert these data into images. Changes in tissue composition or alteration in airflow impact how sounds within the lungs vibrate, and subsequently, how the VRIXP images appear on the system's computer screen. The data can also be stored in a system database for future reference.

The VRIXP procedure takes only minutes and may be performed repeatedly for continuous monitoring. Results are delivered to the physician immediately and can be stored in a system database for future use. The VRIXP has been approved by the U.S. Food and Drug Administration (FDA) for monitoring and recording lung sounds, but has not been approved as a diagnostic instrument. The VRIXP electronic stethoscope is manufactured by Deep Breeze (Or Akiva, Israel).

"Vibration-response imaging enables physicians to effectively record and monitor lung sounds with the ultimate goal of improving the detection and assessment of lung disorders in the future,” said Igal Kushnir, M.D., president and CEO of Deep Breeze. "FDA clearance represents a significant milestone for the company, and we plan to work closely with U.S. interventional pulmonologists to bring this advanced pulmonary imaging system to patients suffering from lung disorders.”


Related Links:
Deep Breeze